300764 Product Name: Lenvatinib, een farmaceutisch aanvaardbaar zout daarvan, of een hydraat daarvan
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 02/05/2024 | Outgoing Correspondence | Decision extension duration | 1 | /9/7/1/9/0/0800009179/docs/300764_13_602724l504c.pdf | ||
| 02/05/2024 | Certificate | Certificate | 1 | /9/7/1/9/0/0800009179/docs/300764_14_spcxcertificate20240502102828443.pdf | ||
| 22/04/2024 | Outgoing Correspondence | Confirmation receipt request for extension | 2 | /9/7/1/9/0/0800009179/docs/300764_24_601436l505.pdf | ||
| 17/04/2024 | SPC Documents | Accompanying letter SPC | 6 | /9/7/1/9/0/0800009179/docs/300764_15_supplprotectioncertificate20240419024850148.pdf | ||
| 17/04/2024 | Application Form | First filed application form | 4 | /9/7/1/9/0/0800009179/docs/300764_16_applicationform20240419024629832.pdf | ||
| 17/04/2024 | SPC Documents | Annex SPC | 18 | /9/7/1/9/0/0800009179/docs/300764_17_supplprotectioncertificate20240419025607984.pdf | ||
| 17/04/2024 | SPC Documents | Annex SPC | 2 | /9/7/1/9/0/0800009179/docs/300764_18_supplprotectioncertificate20240419025607974.pdf | ||
| 17/04/2024 | SPC Documents | Marketing Authorization SPC | 3 | /9/7/1/9/0/0800009179/docs/300764_19_supplprotectioncertificate20240422101959618.pdf | ||
| 17/04/2024 | SPC Documents | Annex SPC | 67 | /9/7/1/9/0/0800009179/docs/300764_20_supplprotectioncertificate20240422102019162.pdf | ||
| 17/04/2024 | SPC Documents | Annex SPC | 1 | /9/7/1/9/0/0800009179/docs/300764_21_supplprotectioncertificate20240419024918551.pdf | ||
| 17/04/2024 | SPC Documents | Annex SPC | 1 | /9/7/1/9/0/0800009179/docs/300764_22_supplprotectioncertificate20240419025807931.pdf | ||
| 17/04/2024 | SPC Documents | Summary of the characteristics of the product | 43 | /9/7/1/9/0/0800009179/docs/300764_23_supplprotectioncertificate20240419025607949.pdf | ||
| 29/12/2015 | SPC Documents | Certificate SPC | 1 | /9/7/1/9/0/0800009179/docs/300764_1_supplprotectioncertificate20201209040335266.pdf | ||
| 29/12/2015 | Outgoing Correspondence | Outgoing Letter | 1 | /9/7/1/9/0/0800009179/docs/300764_3_outgoingcorrespondence20201209040435066.pdf | ||
| 21/10/2015 | Outgoing Correspondence | Outgoing Letter | 1 | /9/7/1/9/0/0800009179/docs/300764_12_11842l505.pdf | ||
| 16/10/2015 | Application Form | First filed application form | 3 | /9/7/1/9/0/0800009179/docs/300764_0_applicationform20151020043241308.pdf | ||
| 16/10/2015 | SPC Documents | Annex SPC | 3 | /9/7/1/9/0/0800009179/docs/300764_2_supplprotectioncertificate20201209035824566.pdf | ||
| 16/10/2015 | SPC Documents | Summary of the characteristics of the product | 41 | /9/7/1/9/0/0800009179/docs/300764_4_supplprotectioncertificate20201209034905232.pdf | ||
| 16/10/2015 | SPC Documents | Annex SPC | 2 | /9/7/1/9/0/0800009179/docs/300764_5_supplprotectioncertificate20201209034905305.pdf | ||
| 16/10/2015 | Claims | First filed claims | 20 | /9/7/1/9/0/0800009179/docs/300764_6_claims20201209035625972.pdf | ||
| 16/10/2015 | SPC Documents | Annex SPC | 2 | /9/7/1/9/0/0800009179/docs/300764_7_supplprotectioncertificate20201209035327087.pdf | ||
| 16/10/2015 | SPC Documents | Annex SPC | 1 | /9/7/1/9/0/0800009179/docs/300764_8_supplprotectioncertificate20201209034400084.pdf | ||
| 16/10/2015 | SPC Documents | Annex SPC | 17 | /9/7/1/9/0/0800009179/docs/300764_9_supplprotectioncertificate20201209034905358.pdf | ||
| 16/10/2015 | SPC Documents | Marketing Authorization SPC | 7 | /9/7/1/9/0/0800009179/docs/300764_10_supplprotectioncertificate20151020043241525.pdf | ||
| 16/10/2015 | Incoming Correspondence Paper | Accompanying letter incoming document | 4 | /9/7/1/9/0/0800009179/docs/300764_11_incomingcorrespondencepaper20151020043241460.pdf |